13F filer · CIK 1649339 ↗
Scion Asset Management
You are looking at Q2 2016. See the latest, Q3 2025 →
Reported value
$45.5M
−11% on the quarter before
Positions
6
2 new · 4 sold out
Top 10
100.0%
of the value
Est. gain
+$4.2M
on stocks held all quarter
Est. return
+15.5%
on those stocks since Q1 2016
Positions as of Jun 30, 2016, from Scion Asset Management's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2016. Striped tiles are options.
Largest buys
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alphabet~$10.4MNew · 0.0% → 22.8%+15,000 shares
- Neophotonics Corp~$2.9MNew · 0.0% → 6.3%+300,000 shares
- Theravance Biopharma Inc~$1.1MAdded · 10.1% → 16.2%+50,000 shares
Largest sells
Since Q1 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Apple~$8.2MSold out · 16.0% → 0.0%−75,000 shares
- Tailored Brands Inc~$7.2MSold out · 14.0% → 0.0%−400,000 shares
- First Solar~$6.8MSold out · 13.4% → 0.0%−100,000 shares
- Gentherm Inc~$2.0MSold out · 3.8% → 0.0%−47,000 shares
Holdings
As of Jun 30, 2016. Changes are in shares against Mar 31, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nexpoint Residential Tr IncCOM · shares 0% · price +39.0% | 24.4% | $11.1M | +$3.1M | ||||||||
| AlphabetCAP STK CL C · shares New | 22.8% | $10.4M | — | ||||||||
| Hca Holdings IncCOM · shares 0% · price −1.3% | 16.9% | $7.7M | −$104,000 | ||||||||
| Theravance Biopharma IncCOM · shares +18% · price +20.7% | 16.2% | $7.4M | +$1.1M | ||||||||
| Amgen IncCOM · shares 0% · price +1.5% | 13.4% | $6.1M | +$89,000 | ||||||||
| Neophotonics CorpCOM · shares New | 6.3% | $2.9M | — | ||||||||
| Total · 6 positions | 100% | $45.5M | +$4.2M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q1 2016 to Q2 2016: 4 stocks held throughout, up $4.2M (+15.5%).
- Nexpoint Residential Tr Inc+$3.1M+39%
- Theravance Biopharma Inc+$1.1M+21%
- Amgen Inc+$89,000+1%
- Hca Holdings Inc−$104,000−1%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2025 | Nov 3, 2025 | $1.38B+139% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $578.3M+190% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $199.2M+157% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $77.4M−40% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $129.8M+147% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $52.5M−49% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $103.5M+9% | SEC ↗ |
| Q4 2023 | Feb 16, 2024 (amended) | $94.6M−4% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $99.0M−94% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.74B+1,524% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $106.9M+130% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $46.5M+13% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $41.3M+1,148% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $3.3M−98% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $201.4M+170% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $74.5M+78% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $41.7M−98% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $2.08B+54% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $1.35B+503% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $224.7M−32% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $330.3M+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $315.3M+267% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $85.9M+4% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $82.3M+38% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $59.6M−36% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $93.6M−5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $98.2M−5% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $103.5M+193% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $35.4M−22% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $45.5M−11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $51.1M | SEC ↗ |